In the present study, the results indicated that the mRNA transcription level of MAP6 was lower in NSCLC specimens than in normal specimens, but this mRNA transcription level was significantly correlated with the clinical stage of NSCLC patients. Here, MAP6 is linked to non-small cell lung carcinoma.